TY - JOUR
T1 - The genetic landscape of 87 ovarian germ cell tumors
AU - Van Nieuwenhuysen, Els
AU - Busschaert, Pieter
AU - Neven, Patrick
AU - Han, Sileny N.
AU - Moerman, Philippe
AU - Liontos, Michalis
AU - Papaspirou, Maria
AU - Kupryjanczyk, Jolanta
AU - Hogdall, Claus
AU - Hogdall, Estrid
AU - Oaknin, Ana
AU - Garcia, Angel
AU - Mahner, Sven
AU - Trillsch, Fabian
AU - Cibula, David
AU - Heitz, Florian
AU - Concin, Nicole
AU - Speiser, Paul
AU - Salvesen, Helga
AU - Sehouli, Jalid
AU - Lambrechts, Diether
AU - Vergote, Ignace
PY - 2018
Y1 - 2018
N2 - Background: Ovarian germ cell tumors (OGCT) are rare gynecological neoplasms, mostly affecting children and young women. The underlying molecular genetic background of these tumors is poorly characterized. Methods: We analyzed somatic copy number aberration (CNA) profiles in 87 OGCT tumors and performed whole exome sequencing (WES) on 24 OGCT tumor and matched germline samples to further elucidate their molecular genetic landscape. Results: The overall mutation rate was very low in OGCT compared to other human cancers, with an average of 0.05 mutations per Mb, consistent with their embryological origin. We identified recurrent mutations in KIT and KRAS, while CNA profiling revealed frequent focal amplifications affecting PIK3CA and AKT1 in yolk sac tumors, recurrent focal deletions affecting chromosomal regions 1p36.32, 2q11.1, 4q28.1, 5p15.33, 5q11.1 and 6q27, as well as gains in chromosome 12p that were present in all tumors, except for pure immature teratomas. Conclusion: We here present the first whole exome sequencing data and to our knowledge the largest CNA study in OGCT. We confirmed that earlier reported KIT mutations were frequent in dysgerminomas and mixed forms with a dysgerminoma component, whereas chromosome 12p gains were present in all histological subtypes except pure immature teratomas. We detected recurrent KRAS mutations, recurrent focal deletions and an enrichment in the PI3K/AKT/PTEN pathway in yolk sac tumors. Several of these aberrations involve targetable pathways, offering novel treatment modalities for OGCT.
AB - Background: Ovarian germ cell tumors (OGCT) are rare gynecological neoplasms, mostly affecting children and young women. The underlying molecular genetic background of these tumors is poorly characterized. Methods: We analyzed somatic copy number aberration (CNA) profiles in 87 OGCT tumors and performed whole exome sequencing (WES) on 24 OGCT tumor and matched germline samples to further elucidate their molecular genetic landscape. Results: The overall mutation rate was very low in OGCT compared to other human cancers, with an average of 0.05 mutations per Mb, consistent with their embryological origin. We identified recurrent mutations in KIT and KRAS, while CNA profiling revealed frequent focal amplifications affecting PIK3CA and AKT1 in yolk sac tumors, recurrent focal deletions affecting chromosomal regions 1p36.32, 2q11.1, 4q28.1, 5p15.33, 5q11.1 and 6q27, as well as gains in chromosome 12p that were present in all tumors, except for pure immature teratomas. Conclusion: We here present the first whole exome sequencing data and to our knowledge the largest CNA study in OGCT. We confirmed that earlier reported KIT mutations were frequent in dysgerminomas and mixed forms with a dysgerminoma component, whereas chromosome 12p gains were present in all histological subtypes except pure immature teratomas. We detected recurrent KRAS mutations, recurrent focal deletions and an enrichment in the PI3K/AKT/PTEN pathway in yolk sac tumors. Several of these aberrations involve targetable pathways, offering novel treatment modalities for OGCT.
KW - Copy number
KW - Exome sequencing
KW - KIT
KW - Mutation rate
KW - Ovarian germ cell tumors
KW - PI3K-AKT-PTEN pathway
U2 - 10.1016/j.ygyno.2018.08.013
DO - 10.1016/j.ygyno.2018.08.013
M3 - Journal article
C2 - 30170975
AN - SCOPUS:85053510414
SN - 0090-8258
VL - 151
SP - 61
EP - 68
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 1
ER -